Table of Contents
Cover image

Metabolic grading of metastatic gastroenteropancreatic neuroendocrine neoplasms has been shown to be possible using whole-body molecular imaging with 18F-FDG PET. See page 1260.
Metabolic grading of metastatic gastroenteropancreatic neuroendocrine neoplasms has been shown to be possible using whole-body molecular imaging with 18F-FDG PET. See page 1260.